Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases
Programme note: RFA-FD-25-020, R01
FDA Office of Orphan Products Development
Shared attributes
- Jurisdiction: United States
- Funding type: Grant
- Area: Rare disease
Programme recordUS-NCATS-PAR-25-450
Funding Atlas programme
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes
Programme note: R21 Clinical Trial Not Allowed
NIH NCATS
Funding typeGrantJurisdictionUnited StatesAreasRare disease
Documented facts
Key facts
- Funder
- NIH NCATS
- Programme
- Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes
- Programme note
- R21 Clinical Trial Not Allowed
- Jurisdiction
- United States
- Funding type
- Grant
- Therapeutic areas
- Rare disease
Source-bound timeline
Supplied dates
These dates were recorded in the Atlas as of 3 October 2026. Confirm current timing with the funder.
- Published deadline
- Published deadline
- Published deadline
- Published deadline